| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1001633179 |
| P356 | DOI | 10.1038/SJ.JHH.1001209 |
| P698 | PubMed publication ID | 11464253 |
| P5875 | ResearchGate publication ID | 11878473 |
| P2093 | author name string | Lip GY | |
| Beevers DG | |||
| Silverman S | |||
| Makin A | |||
| P2860 | cites work | Specific calcium antagonists in the treatment of peripheral vascular disease | Q28244018 |
| Peripheral arterial disease in the elderly: The Rotterdam Study | Q28263428 | ||
| Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
| Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients | Q29619542 | ||
| Role of oxidised low density lipoprotein in atherogenesis | Q33613205 | ||
| Morbidity, Mortality, and Antihypertensive Treatment Effects by Extent of Atherosclerosis in Older Adults With Isolated Systolic Hypertension | Q71948029 | ||
| Comparison of effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients | Q72166720 | ||
| A marked decline in the prevalence and incidence of intermittent claudication in Icelandic men 1968-1986: a strong relationship to smoking and serum cholesterol--the Reykjavik Study | Q72169761 | ||
| Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study | Q72369100 | ||
| Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease | Q72633091 | ||
| Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment | Q73012620 | ||
| Does hypertension confer a prothrombotic state? Virchow's triad revisited | Q73382018 | ||
| The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group | Q73631272 | ||
| Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan | Q73660473 | ||
| The demographics of claudication and the aging of the American population | Q74453590 | ||
| Effect of felodipine on regional blood supply and collateral vascular resistance in patients with peripheral arterial occlusive disease | Q74453630 | ||
| Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension | Q74662421 | ||
| Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure | Q78115432 | ||
| Platelet-induced migration of smooth muscle cells under shear stress | Q78163136 | ||
| Systolic hypertension: a pathogenetic entity. Significance and therapeutic considerations | Q79401906 | ||
| Guidelines for management of hypertension: report of the third working party of the British Hypertension Society | Q33731236 | ||
| Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population | Q34930923 | ||
| Unsuspected renal artery stenosis in peripheral vascular disease | Q35171554 | ||
| Efficacy of doxazosin in specific hypertensive patient groups | Q37076025 | ||
| Chlamydia pneumoniae antibodies in severe essential hypertension | Q37881616 | ||
| Infectious agents and atherosclerotic vascular disease | Q37884375 | ||
| Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. | Q39406623 | ||
| Prevalence of abdominal aortic aneurysm associated with hypertension in an urban population | Q39429255 | ||
| The pathogenesis of atherosclerosis--an update | Q39726917 | ||
| Role of blood pressure in cardiovascular morbidity and mortality | Q39888153 | ||
| Blood pressure response to percutaneous transluminal angioplasty for renovascular hypertension: an overview of published series | Q39905393 | ||
| beta blockade and intermittent claudication: placebo controlled trial of atenolol and nifedipine and their combination | Q40157024 | ||
| Peripheral vascular effects of beta-blockers | Q40652155 | ||
| Intermittent claudication in 8343 men and 21-year specific mortality follow-up | Q40899083 | ||
| Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study | Q40951737 | ||
| Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease | Q41072972 | ||
| The prevalence of peripheral arterial disease in a defined population | Q43564702 | ||
| Mortality amongst patients of the Glasgow Blood Pressure Clinic was high in the 1970s and 80s but has fallen since, why? | Q43796980 | ||
| Intermittent claudication. Incidence in the Framingham Study | Q44241465 | ||
| Evidence of early changes of the brachial artery circulation in borderline hypertension. | Q44478934 | ||
| Mortality over four years in SHEP participants with a low ankle-arm index | Q45141557 | ||
| Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group | Q45335353 | ||
| Relation of a postmortem renal index of hypertension to atherosclerosis and coronary artery size in young men and women. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group | Q46642162 | ||
| Epidemiology of intermittent claudication in middle-aged men. | Q50602370 | ||
| Expansion rates of small abdominal aortic aneurysms. | Q50627781 | ||
| Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. | Q50849218 | ||
| Risk factors and cardiovascular diseases associated with asymptomatic peripheral arterial occlusive disease. The Limburg PAOD Study. Peripheral Arterial Occlusive Disease. | Q50859337 | ||
| Screening for abdominal aortic aneurysm during transthoracic echocardiography in a hypertensive patient population. | Q50928855 | ||
| Intermittent claudication. A risk profile from The Framingham Heart Study. | Q50944777 | ||
| Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: evidence for intermediate elevated levels of intravascular thrombogenesis. | Q51021305 | ||
| Risk factors for peripheral vascular disease in hypertensive subjects with type 2 diabetes mellitus. | Q51603129 | ||
| Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study | Q56287924 | ||
| Effect of renal-artery stenting on progression of renovascular renal failure | Q56970964 | ||
| Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm | Q57240983 | ||
| Mass or high-risk screening for abdominal aortic aneurysm | Q57446295 | ||
| Blood Pressure in Navajo Indians and Its Association With Type 2 Diabetes and Renal and Cardiovascular Disease | Q59531462 | ||
| Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies | Q61651800 | ||
| Captopril for the Treatment of Patients with Hypertension and Peripheral Vascular Disease | Q62256069 | ||
| An atherosclerosis risk factor assessment program for patients with peripheral arterial occlusive disease | Q67977389 | ||
| Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study | Q68076935 | ||
| Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials | Q68314935 | ||
| Abnormal arterial flow pattern in untreated essential hypertension: possible link with the development of atherosclerosis | Q68460262 | ||
| The effects of nifedipine on blood flow in peripheral vascular disease of the lower limbs | Q68705847 | ||
| Mortality in patients of the Glasgow Blood Pressure Clinic | Q69518462 | ||
| Assessment of captopril and nicardipine effects on chronic occlusive arterial disease of the lower extremity using Doppler ultrasound | Q70219194 | ||
| Prevalence of intermittent claudication and its effect on mortality | Q70419412 | ||
| Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique | Q71237633 | ||
| Relation of a postmortem renal index of hypertension to atherosclerosis in youth. The Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group | Q71563403 | ||
| P433 | issue | 7 | |
| P921 | main subject | vascular disease | Q1266890 |
| P304 | page(s) | 447-454 | |
| P577 | publication date | 2001-07-01 | |
| P1433 | published in | Journal of Human Hypertension | Q15746469 |
| P1476 | title | Peripheral vascular disease and hypertension: a forgotten association? | |
| P478 | volume | 15 |
| Q60800106 | A study paradigm integrating prospective epidemiologic cohorts and electronic health records to identify disease biomarkers |
| Q58563980 | American Heart Association High Blood Pressure Protocol 2017: A Literature Review |
| Q59795166 | An Inductive Sensing System to Measure In-Socket Residual Limb Displacements for People Using Lower-Limb Prostheses |
| Q26852616 | Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease? |
| Q30979057 | Effect of beta-blockers on peripheral skin microcirculation in hypertension and peripheral vascular disease |
| Q37307276 | Ethnicity and peripheral artery disease |
| Q36290868 | Hypertension and peripheral arterial disease |
| Q79613532 | Hypertension and peripheral arterial disease |
| Q49894643 | Hypertension with diabetes mellitus complications |
| Q44738528 | Hypotensive activity of auraptene, a monoterpene coumarin from Citrus spp. |
| Q37659222 | Peripheral arterial disease in the Middle East: Underestimated predictor of worse outcome. |
| Q60916930 | Peripheral artery disease risk factors in Jeddah, Saudi Arabia: a retrospective study |
| Q46664849 | Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease |
| Q44676065 | Pulse pressure as a risk factor for peripheral vascular disease in type 2 diabetic patients |
| Q36690383 | Quantitative CMR markers of impaired vascular reactivity associated with age and peripheral artery disease |
| Q44430837 | Serum uric acid in hypertensive patients with and without peripheral arterial disease |
| Q24201969 | Treatment of hypertension in peripheral arterial disease |
| Q24240538 | Treatment of hypertension in peripheral arterial disease |
| Q24248743 | Treatment of hypertension in peripheral arterial disease |
| Q30234498 | Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment |
Search more.